Integra LifeSciences Holdings Balance Sheet Health
Financial Health criteria checks 2/6
Integra LifeSciences Holdings has a total shareholder equity of $1.6B and total debt of $1.9B, which brings its debt-to-equity ratio to 116.3%. Its total assets and total liabilities are $4.1B and $2.5B respectively. Integra LifeSciences Holdings's EBIT is $239.7M making its interest coverage ratio 6.9. It has cash and short-term investments of $677.3M.
Key information
116.3%
Debt to equity ratio
US$1.86b
Debt
Interest coverage ratio | 6.9x |
Cash | US$677.29m |
Equity | US$1.60b |
Total liabilities | US$2.48b |
Total assets | US$4.08b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IL3's short term assets ($1.4B) exceed its short term liabilities ($302.4M).
Long Term Liabilities: IL3's short term assets ($1.4B) do not cover its long term liabilities ($2.2B).
Debt to Equity History and Analysis
Debt Level: IL3's net debt to equity ratio (73.9%) is considered high.
Reducing Debt: IL3's debt to equity ratio has increased from 99.1% to 116.3% over the past 5 years.
Debt Coverage: IL3's debt is not well covered by operating cash flow (7%).
Interest Coverage: IL3's interest payments on its debt are well covered by EBIT (6.9x coverage).